DUSP7 Human siRNA Oligo Duplex (Locus ID 1849)
CAT#: SR301301
DUSP7 (Human) - 3 unique 27mer siRNA duplexes - 2 nmol each
Need single siRNA in bulk? 
                            Get a free quote
                        
CNY 4090.00
货期*
                        7周
                    规格
                        Product images
                    
                
                         推荐一起购买 (3)
                    
                    
                Specifications
| Product Data | |
| Purity | HPLC purified | 
| Quality Control | Tested by ESI-MS | 
| Sequences | Available with shipment | 
| Stability | One year from date of shipment when stored at -20°C. | 
| # of transfections | Approximately 330 transfections/2nmol in 24-well plate under optimized conditions (final conc. 10 nM). | 
| Note | Single siRNA duplex (10nmol) can be ordered. | 
| Reference Data | |
| RefSeq | NM_001947 | 
| Synonyms | MKPX; PYST2 | 
| Components | DUSP7 (Human) - 3 unique 27mer siRNA duplexes - 2 nmol each (Locus ID 1849)Included - SR30004, Trilencer-27 Universal Scrambled Negative Control siRNA Duplex - 2 nmolIncluded - SR30005, RNAse free siRNA Duplex Resuspension Buffer - 2 ml | 
| Summary | Dual-specificity phosphatases (DUSPs) constitute a large heterogeneous subgroup of the type I cysteine-based protein-tyrosine phosphatase superfamily. DUSPs are characterized by their ability to dephosphorylate both tyrosine and serine/threonine residues. DUSP7 belongs to a class of DUSPs, designated MKPs, that dephosphorylate MAPK (mitogen-activated protein kinase) proteins ERK (see MIM 601795), JNK (see MIM 601158), and p38 (see MIM 600289) with specificity distinct from that of individual MKP proteins. MKPs contain a highly conserved C-terminal catalytic domain and an N-terminal Cdc25 (see MIM 116947)-like (CH2) domain. MAPK activation cascades mediate various physiologic processes, including cellular proliferation, apoptosis, differentiation, and stress responses (summary by Patterson et al., 2009 [PubMed 19228121]).[supplied by OMIM, Dec 2009] | 
| Performance Guranteed | OriGene guarantees that at least two of the three Dicer-Substrate duplexes in the kit will provide at least 70% or more knockdown of the target mRNA when used at 10 nM concentration by quantitative RT-PCR when the TYE-563 fluorescent transfection control duplex (cat# SR30002) indicates that >90% of the cells have been transfected and the HPRT positive control (cat# SR30003) provides 90% knockdown efficiency. For non-conforming siRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the siRNA kit. To arrange for a free replacement with newly designed duplexes, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled siRNA control (quantitative RT-PCR data required).  | 
        
Documents
| Product Manuals | 
| FAQs | 
| SDS | 
                         Customer
                                Reviews 
                    
                    
                                Loading...
                            
                        